logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Gene Cartels Biotech Patents In The Age Of Free Trade Luigi Palombi

  • SKU: BELL-1354502
Gene Cartels Biotech Patents In The Age Of Free Trade Luigi Palombi
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Gene Cartels Biotech Patents In The Age Of Free Trade Luigi Palombi instant download after payment.

Publisher: Edward Elgar Pub
File Extension: PDF
File size: 1.17 MB
Pages: 410
Author: Luigi Palombi, Baruch S. Blumberg
ISBN: 9781847208361, 1847208363
Language: English
Year: 2009

Product desciption

Gene Cartels Biotech Patents In The Age Of Free Trade Luigi Palombi by Luigi Palombi, Baruch S. Blumberg 9781847208361, 1847208363 instant download after payment.

Dr. Palombi's work is a comprehensive examination of the law surrounding the complex social and scientific issue of gene patents. He delves into not only the current practice, and its legal and policy justifications, but the entire history of the law surrounding patents on life-forms and natural products. He tears apart the practice, based on his detailed legal analysis, showing that it is not only illogical, but unlawful. In particular, he decimates the myth that cDNA is somehow something "new" or "inventive," and illustrates how the existing case law cannot seriously support the patenting of supposedly "isolated and purified" genes. His legal arguments ought to support current efforts to overturn the practice, either through legislative action, or through lawsuits like that recently brought against Myriad, Inc., for its patent on the BRCA1 and 2 "breast cancer" genes. This book is essential reading for anyone interested in the debate, as well as those whose lives might very well depend on the debate, including anyone with genetic predispositions to diseases, or with monogenic genetic diseases which have or may already be patented.

Related Products